Is A Class-Wide Myocarditis Warning Coming For COVID-19 Vaccines?
Now that multiple vaccines using different platforms seem to be associated with heart inflammation, the FDA and others want more data on whether a common characteristic of the virus or vaccine manufacturing is related.
You may also be interested in...
The change to three vaccine emergency use authorizations was made quietly, most recently for the Novavax vaccine.
The agency also includes a myocarditis warning in the fact sheet for the first protein-based COVID-19 vaccine to reach the US market.
CBER director Peter Marks also wants to work on rare disease gene therapy issues and increase hiring before the end of the year.